ロード中...
Modification of left ventricular hypertrophy by chronic etomoxir treatment
1. Etomoxir (2[6(4-chlorophenoxy)hexyl]oxirane-2-carboxylate), an irreversible carnitine palmitoyltransferase 1 inhibitor, reduces the expression of the myocardial foetal gene programme and the functional deterioration during heart adaption to a pressure-overload. Etomoxir may, however, also improve...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1999
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1565820/ https://ncbi.nlm.nih.gov/pubmed/10077244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0702312 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|